Raphaël V. Gayet, PhD is the co-founder and CSO of Florey Biosciences. A life sciences entrepreneur and synthetic biology specialist, Raphaël was initially trained as a biological engineer in France (ENS Lyon) and Switzerland (EPFL), he completed his PhD at the Massachusetts Institute of Technology, focusing on nucleic acid technologies for material sciences and RNA therapeutics. He then joined the Wyss Institute for Biologically Inspired Engineering at Harvard University where he developed engineered probiotics, with an emphasis on metabolic health and diabetes. Today, at Florey Biosciences, Raphaël leads the development of new types of microbes designed for human health, that help make antibiotic use safer.